Azathioprine: Difference between revisions
(contraindications) |
(serious adverse reactions) |
||
| Line 50: | Line 50: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*leukopenia | |||
*thrombocytopenia | |||
*anemia | |||
*myelosuppression | |||
*immunosuppression | |||
*infection | |||
*PML | |||
*GI hypersensitivity rxn | |||
*pancreatitis | |||
*hepatotoxicity | |||
*hepatic veno-occlusive dz | |||
*lymphoma | |||
*malignancy | |||
*acute febrile neutrophilic dermatosis | |||
===Common=== | ===Common=== | ||
Revision as of 02:49, 9 February 2016
Administration
- Type: immunosuppressant
- Dosage Forms: 50
- Routes of Administration: PO (IV form unavailable in US)
- Common Trade Names: Azasan, Imuran
Adult Dosing
Kidney transplant rejection prophylaxis
- 1-3 mg/kg PO qd
- Start: 3-5 mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary
Rheumatoid arthritis, severe
- 1-2.5 mg/kg/day PO divided qd-bid
- Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk
Crohns Disease
- 100-250 mg PO qd
- Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance and fistulizing disease, steroid-sparing effects
Ulcerative colitis
- 100-250 mg PO qd
- Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance, steroid-sparing effects
Pediatric Dosing
Kidney transplant rejection prophylaxis
- 1-3 mg/kg PO qd
- Start: 3-5 mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary
Juvenile idiopathic arthritis, severe
- 1-2.5 mg/kg/day PO divided qd-bid
- Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk
Special Populations
- Pregnancy Rating: Pregnancy Category D
- Lactation risk: possibly unsafe
Renal Dosing
- Adult: CrCl 10-50: decr. dose 25%; CrCl <10: decr. dose 50%; HD: give 0.25 mg/kg supplement; PD: not defined
- Pediatric: CrCl 10-50: decr. dose 25% or give q36h; CrCl <10: decr. dose 50% or give q48h; HD: give supplement; PD: not defined
Hepatic Dosing
- Adult: not defined; caution advised
- Pediatric: not defined; caution advised
Contraindications
- Allergy to class/drug
- pregnancy (RA use)
- caution if renal impairment
- caution if prior alkylating agents
Adverse Reactions
Serious
- leukopenia
- thrombocytopenia
- anemia
- myelosuppression
- immunosuppression
- infection
- PML
- GI hypersensitivity rxn
- pancreatitis
- hepatotoxicity
- hepatic veno-occlusive dz
- lymphoma
- malignancy
- acute febrile neutrophilic dermatosis
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
